NCT07311590

Brief Summary

The aim of the first-in-human clinical trial is to evaluate the feasibility of performing colonoscopic polypectomy with a novel colonic intraluminal endoscopic support structure (CIESS) in-situ

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Dec 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Dec 2025Dec 2026

First Submitted

Initial submission to the registry

December 8, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

December 18, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 31, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2026

Last Updated

December 31, 2025

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 8, 2025

Last Update Submit

December 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ability to deploying CIESS in a single attempt

    Primary outcome measure is whether the CIESS can be deployed successfully in a single attempt - this is a measure of the feasibility of deploying the CIESS during colonoscopy. This outcome will be recorded as "successfully deployed in a single attempt or unsuccessfully deployed in a single attempt"

    From enrollment to end of treatment at 4 weeks

Study Arms (1)

Colonoscopy and polypectomy with Colonic Intraluminal Endoscopic Support Structure in-situ

EXPERIMENTAL
Device: Colonic Intraluminal Endoscopic Support Structure

Interventions

During colonoscopy, if a left-sided colonic polyps is identified, the colonic intraluminal endoscopic support structure (CIESS) will be deployed. Routine polypectomy will be performed. CIESS will be retrieved after polypectomy is completed. Colonoscopy will be completed as per normal routine.Other Name:

Colonoscopy and polypectomy with Colonic Intraluminal Endoscopic Support Structure in-situ

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Positive fecal occult blood test
  • ASA I/II
  • only patients with left-sided colonic polyp during colonoscopy will be included into the study eventually

You may not qualify if:

  • History of malignancy, gastrointestinal tract/ abdominal surgery, diverticular disease, abdominal/ pelvic radiation
  • Pregnancy patient
  • cognitively impaired patients
  • Patients on blood thinners or anticoagulants
  • ASA III / ASA IV

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Colonic Polyps

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2025

First Posted

December 31, 2025

Study Start

December 18, 2025

Primary Completion (Estimated)

December 18, 2026

Study Completion (Estimated)

December 18, 2026

Last Updated

December 31, 2025

Record last verified: 2025-12